Consensus IDEXX Laboratories, Inc.

Stocks

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 02:40:40 15/10/26 am AEDT			5-day change	1st Jan Change
526.54 ^USD	+1.20%		+3.84%	-22.23%

12/10	KeyBanc Initiates IDEXX Laboratories at Sector Weight	MT
01/10	IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI	MT

Evolution of the Average Target: IDEXX Laboratories, Inc.

Evolution of the Target Price: IDEXX Laboratories, Inc.

Changes in Analyst Recommendations: IDEXX Laboratories, Inc.

6c4166d3f3a378d9815323b.Nv53gocTaFLIre9kwatKcbDGpI-KZ6qNM5bh98-PqYY.BaQxxtdgESKS5Ygvm_k8FOH-7O35FJq8XMm0xJrc06tRuQfbt303ZoLs2w~2fde2d5daab73ab6fedaeb1e990663b3

Analysts' recommendations: IDEXX Laboratories, Inc.

12/10	KeyBanc Initiates IDEXX Laboratories at Sector Weight	MT
11/08	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
06/08	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
06/08	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
05/08	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
28/07	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
28/07	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
13/07	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
06/05	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
06/05	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
28/04	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
27/04	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
15/04	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
14/04	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
31/03	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
09/02	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT
06/02	Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating	MT
05/02	Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850	MT
04/02	Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830	MT
04/02	UBS Adjusts IDEXX Laboratories PT to $730 From $750	MT
03/02	Leerink Partners Adjusts Price Target on IDEXX Laboratories to $760 From $785	MT
03/02	BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830	MT
03/02	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700	MT
10/12	Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target	MT
11/11	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700	MT

More recommendations

Veterinary Medical Equipment & Supplies

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IDEXX LABORATORIES, INC.					+34.79%
	ABBOTT LABORATORIES					+17.64%
	MEDTRONIC PLC					+12.25%
	STRYKER CORPORATION					+28.34%
	ESSILORLUXOTTICA					+53.08%
	CENCORA, INC.					+12.13%
	HOYA CORPORATION					+19.3%
	BECTON, DICKINSON AND COMPANY					+3.58%
	DEXCOM, INC.					+13.4%
	MEDLINE INC.					+24.43%
	Average					+21.89%
	Weighted average by Cap.					+21.62%